論文 - 森瀬 昌宏
-
Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR 査読有り 国際誌
Matsuzawa Reiko, Morise Masahiro, Kinoshita Fumie, Tanaka Ichidai, Koyama Junji, Kimura Tomoki, Kondoh Yasuhiro, Tanaka Taro, Shima Koichiro, Hase Tetsunari, Wakahara Keiko, Ishii Makoto, Hashimoto Naozumi
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2022年8月
-
Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer A retrospective observational study 査読有り 国際誌
Oi Hajime, Matsuda Toshiaki, Kimura Tomoki, Morise Masahiro, Yamano Yasuhiko, Yokoyama Toshiki, Kataoka Kensuke, Kondoh Yasuhiro
MEDICINE 101 巻 ( 6 ) 頁： e28863 2022年2月
-
Trastuzumab emtansine for patients with non-small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations 査読有り 国際誌
Iwama Eiji, Zenke Yoshitaka, Sugawara Shunichi, Daga Haruko, Morise Masahiro, Yanagitani Noriko, Sakamoto Tomohiro, Murakami Haruyasu, Kishimoto Junji, Matsumoto Shingo, Nakanishi Yoichi, Goto Koichi, Okamoto Isamu
EUROPEAN JOURNAL OF CANCER 162 巻 頁： 99 - 106 2022年2月
-
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE 査読有り 国際誌
Hata Akito, Okamoto Isamu, Inui Naoki, Okada Morihito, Morise Masahiro, Akiyoshi Kohei, Takeda Masayuki, Watanabe Yasutaka, Sugawara Shunichi, Shinagawa Naofumi, Kubota Kaoru, Saeki Toshiaki, Tamura Tomohide
JOURNAL OF CLINICAL ONCOLOGY 40 巻 ( 2 ) 頁： 180 - + 2022年1月
-
Is area under the curve the best parameter for carboplatin induced emetic risk stratification? 査読有り 国際誌
Ozone Sachiko, Ichikawa Kazuya, Morise Masahiro, Matsui Akira, Kinoshita Fumie, Matsuzawa Reiko, Koyama Junji, Tanaka Ichidai, Hashimoto Naozumi
NAGOYA JOURNAL OF MEDICAL SCIENCE 83 巻 ( 4 ) 頁： 773 - 785 2021年11月
-
The current issues and future perspective of artificial intelligence for developing new treatment strategy in non-small cell lung cancer: harmonization of molecular cancer biology and artificial intelligence 査読有り 国際誌
Tanaka Ichidai, Furukawa Taiki, Morise Masahiro
CANCER CELL INTERNATIONAL 21 巻 ( 1 ) 頁： 454 2021年8月
-
Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma. 査読有り 国際誌
Nakagawa K, Kijima T, Okada M, Morise M, Kato M, Hirano K, Fujimoto N, Takenoyama M, Yokouchi H, Ohe Y, Hida T, Aoe K, Kishimoto T, Hirokawa M, Matsuki H, Kaneko Y, Yamada T, Morimoto C, Takeda M
JTO clinical and research reports 2 巻 ( 6 ) 頁： 100178 2021年6月
-
Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With <i>EGFR</i> Mutations. 査読有り 国際誌
Ninomiya K, Teraoka S, Zenke Y, Kenmotsu H, Nakamura Y, Okuma Y, Tamiya A, Nosaki K, Morise M, Aokage K, Oya Y, Kozuki T, Sakamoto T, Tanaka K, Tanaka H, Tanizaki J, Miura S, Mizutani H, Miyauchi E, Yamaguchi O, Ebi N, Goto Y, Sasaki T, Daga H, Morita S, Yamanaka T, Amano S, Hasegawa K, Imamura CK, Suzuki K, Nakajima K, Nishimoto H, Oizumi S, Hida T, Hotta K, Takiguchi Y
JTO clinical and research reports 2 巻 ( 1 ) 頁： 100107 2021年1月
-
新型コロナウイルス感染症に対するSARS-CoV-2抗体検査試薬の検討―抗原種の違いによる特性と抗体アイソタイプの関連― 査読有り 国際誌
金 貞姫, 菊地 良介, 鈴木 敦夫, 度會 理佳, 横山 覚, 森瀬 昌宏, 八木 哲也, 松下 正
医学検査 69 巻 ( 4 ) 頁： 554 - 561 2020年10月
-
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC 査読有り 国際共著 国際誌
Herbst Roy S., Giaccone Giuseppe, de Marinis Filippo, Reinmuth Niels, Vergnenegre Alain, Barrios Carlos H., Morise Masahiro, Felip Enriqueta, Andric Zoran, Geater Sarayut, Ozguroglu Mustafa, Zou Wei, Sandler Alan, Enquist Ida, Komatsubara Kimberly, Deng Yu, Kuriki Hiroshi, Wen Xiaohui, McCleland Mark, Mocci Simonetta, Jassem Jacek, Spigel David R.
NEW ENGLAND JOURNAL OF MEDICINE 383 巻 ( 14 ) 頁： 1328 - 1339 2020年10月
-
Multicenter, placebo-controlled, double-blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy 査読有り 国際誌
Sugawara Shunichi, Inui Naoki, Kanehara Masashi, Morise Masahiro, Yoshimori Kozo, Kumagai Toru, Fukui Tomoya, Minato Koichi, Iwashima Akira, Takeda Yuichiro, Kubota Kaoru, Saeki Toshiaki, Tamura Tomohide
CANCER 125 巻 ( 22 ) 頁： 4076 - 4083 2019年11月
-
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV 査読有り 国際誌
Akamatsu Hiroaki, Ninomiya Kiichiro, Kenmotsu Hirotsugu, Morise Masahiro, Daga Haruko, Goto Yasushi, Kozuki Toshiyuki, Miura Satoru, Sasaki Takaaki, Tamiya Akihiro, Teraoka Shunsuke, Tsubata Yukari, Yoshioka Hiroshige, Hattori Yoshihiro, Imamura Chiyo K., Katsuya Yuki, Matsui Reiko, Minegishi Yuji, Mizugaki Hidenori, Nosaki Kaname, Okuma Yusuke, Sakamoto Setsuko, Sone Takashi, Tanaka Kentaro, Umemura Shigeki, Yamanaka Takeharu, Amano Shinsuke, Hasegawa Kazuo, Morita Satoshi, Nakajima Kazuko, Maemondo Makoto, Seto Takashi, Yamamoto Nobuyuki
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 24 巻 ( 7 ) 頁： 731 - 770 2019年7月
-
12）高齢者肺癌の臨床 国際誌
長谷川 好規, 森瀬 昌宏
日本内科学会雑誌 106 巻 ( 9 ) 頁： 1986 - 1990 2017年9月
-
Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis 査読有り 国際誌
Gen Soei, Tanaka Ichidai, Morise Masahiro, Koyama Junji, Kodama Yuta, Matsui Akira, Miyazawa Ayako, Hase Tetsunari, Hibino Yoshitaka, Yokoyama Toshihiko, Kimura Tomoki, Yoshida Norio, Sato Mitsuo, Hashimoto Naozumi
BMC CANCER 22 巻 ( 1 ) 頁： 654 2022年6月
-
Amelanotic Malignant Melanoma with a BRAF V600E Mutation Mimicking Primary Lung Cancer 査読有り 国際誌
Matsuzawa Reiko, Morise Masahiro, Tanaka Ichidai, Hayai Shunsaku, Tamiya Yutaro, Koyama Junji, Hase Tetsunari, Wakahara Keiko, Kim Deoksu, Shimoyama Yoshie, Hashimoto Naozumi
INTERNAL MEDICINE 61 巻 ( 5 ) 頁： 703 - 708 2022年5月
-
Resistance to mutant KRASV12-induced senescence in an hTERT/Cdk4-immortalized normal human bronchial epithelial cell line 査読有り 国際共著
Muraki N, Yamada M, Doki H, Nakai R, Komeda K, Goto D, Kawabe N, Matsuoka K, Matsushima M, Kawabe T, Tanaka I, Morise M, Shay JW, Minna JD, Sato M.
Exp Cell Res 414 巻 ( 1 ) 頁： 113053 2022年5月
-
Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE) 査読有り 国際誌
Hata Akito, Shiraishi Yoshimasa, Inui Naoki, Okada Morihito, Morise Masahiro, Akiyoshi Kohei, Takeda Masayuki, Watanabe Yasutaka, Sugawara Shunichi, Shinagawa Naofumi, Kubota Kaoru, Saeki Toshiaki, Tamura Tomohide
ONCOLOGY AND THERAPY 2022年3月
-
INSIGHT 2: a Phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance 査読有り 国際共著 国際誌
Smit Egbert F., Dooms Christophe, Raskin Jo, Nadal Ernest, Tho Lye M., Le Xiuning, Mazieres Julien, Hin How S., Morise Masahire, Zhu Viola W., Tan Daniel, Holmberg Kristina H., Ellers-Lenz Barbara, Adrian Svenja, Brutlach Sabine, Schumacher Karl M., Karachaliou Niki, Wu Yi-Long
FUTURE ONCOLOGY 18 巻 ( 9 ) 頁： 1039 - 1054 2022年3月
-
Current Immunotherapeutic Strategies Targeting the PD-1/PD-L1 Axis in Non-Small Cell Lung Cancer with Oncogenic Driver Mutations 査読有り 国際誌
Tanaka Ichidai, Morise Masahiro
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 23 巻 ( 1 ) 2022年1月
-
A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer 査読有り 国際誌
Yasuda Hiroyuki, Ichihara Eiki, Sakakibara-Konishi Jun, Zenke Yoshitaka, Takeuchi Shinji, Morise Masahiro, Hotta Katsuyuki, Sato Mineyoshi, Matsumoto Shingo, Tanimoto Azusa, Matsuzawa Reiko, Kiura Katuyuki, Takashima Yuta, Yano Seiji, Koyama Junji, Fukushima Takahiro, Hamamoto Junko, Terai Hideki, Ikemura Shinnosuke, Takemura Ryo, Goto Koichi, Soejima Kenzo
LUNG CANCER 162 巻 頁： 140 - 146 2021年12月